华森制药：克唑替尼胶囊预计明年底上市销售

Core Viewpoint - Huason Pharmaceutical (002907) announced that its crizotinib capsules are currently under patent protection by the original research company and are expected to be available for sale by the end of next year [1] Company Summary - The sales of the drug are influenced by various industry policies, and the company is currently unable to estimate the sales revenue [1]